The other way that ceramide is known to promote insulin resistance is to reduce Akt/PKB phosphorylation through a process dependent on the activation of atypical protein kinase C (aPKC) λ/ζ isoforms [102,103]. The gene discussed is AKT1; the disease is Insulin resistance.